l General Information |
Product Name | Silmitasertib (CX-4945) |
General description | Silmitasertib is a potent and selective inhibitor of CK2 (casein kinase 2). |
Synonym | 5-(3-chloroanilino)benzo[c][2,6]naphthyridine-8-carboxylic acid |
Purity | ≥98.0%(HPLC) | CAS Number | 1009820-21-6 |
Formula | C19H12ClN3O2 | Molecular Weight | 349.77 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Solid |
Solubility(25℃) | DMSO | ≥15mg/mL |
Ethanol | Insoluble |
Water | Insoluble |
l Biological Information |
Biochem/Physiol
Actions | Silmitasertib (CX-4945) is a potent and selective inhibitor of CK2 (casein kinase 2) with IC50 of 1 nM in a cell-free assay, less potent to Flt3, Pim1 and CDK1 (inactive in cell-based assay). |
l Storage |
Storage temp. | -20℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |